| Home > Authorities > Institutes > Record #147448 |
A420
Personalisierte Medizinische Onkologie| ID | I:(DE-He78)A420-20160331 |
All known publications ...
Download: BibTeX | EndNote XML, Text | RIS |
Journal Article
TISSUE-SPECIFIC SPATIAL REGULATION OF INNATE IMMUNE CHECKPOINTS IN CANCER.
Cancer discovery nn, nn (2026) [10.1158/2159-8290.CD-25-2112]
BibTeX |
EndNote:
XML,
Text |
RIS
Journal Article
Saturation mutagenesis identifies activating and resistance-inducing FGFR kinase domain mutations.
Nature genetics 58(1), 157-168 (2026) [10.1038/s41588-025-02431-8]
BibTeX |
EndNote:
XML,
Text |
RIS
Journal Article
Wuhan strain of SARS-CoV-2 triggers activation of immune evasion machinery similar to the one operated by cancer cells.
Frontiers in immunology 16, 1599352 (2025) [10.3389/fimmu.2025.1599352]
Fulltext by Pubmed Central
BibTeX |
EndNote:
XML,
Text |
RIS
Journal Article
Treatment outcome of NSCLC patients with BRAFnon-V600E mutations: a retrospective, multicentre analysis within the national Network Genomic Medicine (nNGM) Lung Cancer in Germany.
ESMO open 10(8), 105124 (2025) [10.1016/j.esmoop.2025.105124]
BibTeX |
EndNote:
XML,
Text |
RIS
Journal Article
Functional Characterization of Variants of Unknown Significance of Fibroblast Growth Factor Receptors 1-4 and Comparison With AI Model-Based Prediction.
JCO precision oncology 9(9), e2400847 (2025) [10.1200/PO-24-00847]
BibTeX |
EndNote:
XML,
Text |
RIS
Journal Article (Letter)
Thoracic Oncology Highlights from the European Society for Medical Oncology Annual Meeting 2024: Non-targeted therapy in Non-Small Cell Lung Cancer (NSCLC), Small Cell Lung Cancer (SCLC) and Thymic Epithelial Tumors (TET)
Oncology research and treatment 48, 464–470 (2025) [10.1159/000545493]
BibTeX |
EndNote:
XML,
Text |
RIS
Journal Article
ESMO Precision Oncology Working Group recommendations on the structure and quality indicators for molecular tumour boards in clinical practice.
Annals of oncology 36(6), 614-625 (2025) [10.1016/j.annonc.2025.02.009]
BibTeX |
EndNote:
XML,
Text |
RIS
Journal Article
Bemcentinib as monotherapy and in combination with low-dose cytarabine in acute myeloid leukemia patients unfit for intensive chemotherapy: a phase 1b/2a trial.
Nature Communications 16(1), 2846 (2025) [10.1038/s41467-025-58179-6]
BibTeX |
EndNote:
XML,
Text |
RIS
Journal Article
Clinical benefit of additional whole-exome sequencing over panel sequencing in an all-comer real-world molecular tumor board.
ESMO open 10(12), 105894 (2025) [10.1016/j.esmoop.2025.105894]
BibTeX |
EndNote:
XML,
Text |
RIS
Journal Article
Targeting tumoral heterogeneity in lung cancer: a novel, CT-texture-guided targeted biopsy approach with exome sequencing.
npj precision oncology 9(1), 342 (2025) [10.1038/s41698-025-01148-5]
Fulltext by Pubmed Central
BibTeX |
EndNote:
XML,
Text |
RIS
All known publications ...
Download: BibTeX | EndNote XML, Text | RIS |